PL2413718T3 - Zastosowanie kwasu arachidonowego do zmniejszenia ryzyka insulinooporności w późniejszym życiu - Google Patents
Zastosowanie kwasu arachidonowego do zmniejszenia ryzyka insulinooporności w późniejszym życiuInfo
- Publication number
- PL2413718T3 PL2413718T3 PL10711219T PL10711219T PL2413718T3 PL 2413718 T3 PL2413718 T3 PL 2413718T3 PL 10711219 T PL10711219 T PL 10711219T PL 10711219 T PL10711219 T PL 10711219T PL 2413718 T3 PL2413718 T3 PL 2413718T3
- Authority
- PL
- Poland
- Prior art keywords
- risk
- life
- reduction
- insulin resistance
- arachidonic acid
- Prior art date
Links
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 title 2
- 206010022489 Insulin Resistance Diseases 0.000 title 1
- 229940114079 arachidonic acid Drugs 0.000 title 1
- 235000021342 arachidonic acid Nutrition 0.000 title 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pediatric Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09157086 | 2009-04-01 | ||
EP10711219.5A EP2413718B1 (en) | 2009-04-01 | 2010-03-26 | Use of arachidonic acid for the reduction of the risk of insulin resistance later in life |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2413718T3 true PL2413718T3 (pl) | 2017-08-31 |
Family
ID=40790646
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL10711219T PL2413718T3 (pl) | 2009-04-01 | 2010-03-26 | Zastosowanie kwasu arachidonowego do zmniejszenia ryzyka insulinooporności w późniejszym życiu |
Country Status (15)
Country | Link |
---|---|
US (2) | US9480670B2 (pl) |
EP (1) | EP2413718B1 (pl) |
CN (1) | CN102368913A (pl) |
AU (1) | AU2010230362B2 (pl) |
BR (1) | BRPI1014923A2 (pl) |
CA (1) | CA2755077A1 (pl) |
CL (1) | CL2011002405A1 (pl) |
ES (1) | ES2570774T3 (pl) |
MX (1) | MX2011010229A (pl) |
MY (1) | MY161505A (pl) |
PL (1) | PL2413718T3 (pl) |
RU (1) | RU2559646C2 (pl) |
SG (1) | SG173914A1 (pl) |
TW (1) | TW201039759A (pl) |
WO (1) | WO2010112429A1 (pl) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2514435A1 (en) * | 2011-04-19 | 2012-10-24 | Nestec S.A. | Infant formula for use in the prevention of cardiovascular diseases |
RU2604503C2 (ru) * | 2011-10-18 | 2016-12-10 | Нестек С.А. | Композиция для применения при повышении чувствительности к инсулину и/или снижении инсулинорезистентности |
TWI472300B (zh) * | 2011-12-27 | 2015-02-11 | Abbott Lab | 包含核苷酸及/或類胡蘿蔔素之低卡路里嬰兒配方於降低後續生命中不利健康效應之用途 |
SG11201405709SA (en) * | 2012-03-14 | 2014-10-30 | Abbott Lab | Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids |
WO2014159967A1 (en) | 2013-03-13 | 2014-10-02 | Abbott Laboratories | A composition for enhancing newborn infant cognitive, brain and/or cns development and method of using same |
SG11201507210XA (en) | 2013-03-13 | 2015-10-29 | Abbott Lab | Infant nutritional product with rrr alpha-tocopherol |
AU2014356485A1 (en) * | 2013-11-29 | 2016-03-03 | Nestec S.A. | Infant nutrition for improvement in insulin sensitivity later in life |
US20180153951A1 (en) * | 2016-12-05 | 2018-06-07 | Mead Johnson Nutrition Company | Methods for Inducing Adipocyte Browning, Improving Metabolic Flexibility, and Reducing Detrimental White Adipocyte Tissue Deposition and Dysfunction |
BR112019028006A2 (pt) | 2017-06-30 | 2020-07-07 | N.V. Nutricia | composição nutricional, uso de uma combinação de bifidobacterium breve e oligossacarídeos não digeríveis, e método para prevenir e/ou reduzir o risco de ocorrência de hipercolesterolemia e/ou aterosclerose |
EP4159224A1 (en) | 2017-06-30 | 2023-04-05 | N.V. Nutricia | Synbiotic composition for preventing chronic inflammation |
CN116622514B (zh) * | 2023-07-21 | 2023-10-20 | 南京师范大学 | 提高微生物菌体和/或微生物油脂中多不饱和脂肪酸含量的调控方法及应用 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ241359A (en) * | 1991-01-24 | 1994-08-26 | Martek Corp | Supplementation of infant formula by the addition of at least two different polyunsaturated fatty acids obtained from at least two different microbial sources; compositions comprising such oils |
US6200624B1 (en) * | 1996-01-26 | 2001-03-13 | Abbott Laboratories | Enteral formula or nutritional supplement containing arachidonic and docosahexaenoic acids |
US6077828A (en) * | 1996-04-25 | 2000-06-20 | Abbott Laboratories | Method for the prevention and treatment of cachexia and anorexia |
PL343902A1 (en) * | 1997-02-21 | 2001-09-10 | Abbott Lab | Methods of and compositions for reducing enteritis and colitis morbidity rate |
CN1660065A (zh) * | 1997-03-27 | 2005-08-31 | 布里斯托尔-迈尔斯斯奎布公司 | 二十二碳六烯酸和花生四烯酸促进不足月婴儿生长的用途 |
EP0880902A1 (fr) | 1997-05-27 | 1998-12-02 | Nestlé Produkte AG | Procédé de traitement d'une matiére première lactosérique |
DK1239022T3 (da) | 2001-03-09 | 2009-07-20 | Nestle Sa | Olie indeholdende en eller flere langkædede flerumættede fedtsyrer hidrörende fra biomasse, fremgangsmåde til fremstilling, levnedsmiddel, næringsmiddelsammensætning, kosmetisk sammensætning eller farmaceutisk sammensætning indeholdende denne |
US6753350B1 (en) * | 2003-03-24 | 2004-06-22 | Bristol-Myers Squibb Company | Method to reduce the incidence of intraventricular hemorrhage in preterm infants |
EP1622467A1 (en) * | 2003-05-05 | 2006-02-08 | Denofa AS | Fish oils with an altered fatty acid profile, method of producing same and their use |
EP1643862A1 (en) * | 2003-06-24 | 2006-04-12 | University of Kansas Medical Center | Infant formula |
US7759507B2 (en) * | 2003-09-05 | 2010-07-20 | Abbott Laboratories | Lipid system and methods of use |
CA2574360A1 (en) * | 2004-07-19 | 2006-01-26 | N.V. Nutricia | A preparation for use of aspartate for regulating glucose levels in blood |
WO2008054192A1 (en) | 2006-11-02 | 2008-05-08 | N.V. Nutricia | Use of nutritional compositions for preventing disorders |
EP1962617A2 (en) * | 2005-12-23 | 2008-09-03 | N.V. Nutricia | Infant nutritional compositions for preventing obesity |
WO2007100561A2 (en) | 2006-02-28 | 2007-09-07 | Bristol-Myers Squibb Company | Use of dha and ara in the preparation of a composition for preventing or treating obesity |
WO2007100562A2 (en) * | 2006-02-28 | 2007-09-07 | Bristol-Myers Squibb Company | Use of dha and ara in the preparation of a composition for reducing triglyceride levels |
EP1932437A1 (en) * | 2006-12-15 | 2008-06-18 | Nestec S.A. | Infant formula |
-
2010
- 2010-03-26 ES ES10711219T patent/ES2570774T3/es active Active
- 2010-03-26 EP EP10711219.5A patent/EP2413718B1/en active Active
- 2010-03-26 US US13/260,842 patent/US9480670B2/en active Active
- 2010-03-26 CN CN2010800147082A patent/CN102368913A/zh active Pending
- 2010-03-26 PL PL10711219T patent/PL2413718T3/pl unknown
- 2010-03-26 WO PCT/EP2010/054025 patent/WO2010112429A1/en active Application Filing
- 2010-03-26 AU AU2010230362A patent/AU2010230362B2/en active Active
- 2010-03-26 BR BRPI1014923-6A patent/BRPI1014923A2/pt not_active Application Discontinuation
- 2010-03-26 MY MYPI2011004161A patent/MY161505A/en unknown
- 2010-03-26 CA CA2755077A patent/CA2755077A1/en not_active Abandoned
- 2010-03-26 MX MX2011010229A patent/MX2011010229A/es active IP Right Grant
- 2010-03-26 RU RU2011144102/13A patent/RU2559646C2/ru active
- 2010-03-26 SG SG2011064169A patent/SG173914A1/en unknown
- 2010-04-01 TW TW099110173A patent/TW201039759A/zh unknown
-
2011
- 2011-09-29 CL CL2011002405A patent/CL2011002405A1/es unknown
-
2013
- 2013-04-09 US US13/859,011 patent/US9480671B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
AU2010230362A1 (en) | 2011-10-06 |
EP2413718A1 (en) | 2012-02-08 |
CN102368913A (zh) | 2012-03-07 |
BRPI1014923A2 (pt) | 2015-09-01 |
CL2011002405A1 (es) | 2012-03-23 |
WO2010112429A1 (en) | 2010-10-07 |
CA2755077A1 (en) | 2010-10-07 |
SG173914A1 (en) | 2011-10-28 |
RU2011144102A (ru) | 2013-05-10 |
US9480670B2 (en) | 2016-11-01 |
TW201039759A (en) | 2010-11-16 |
EP2413718B1 (en) | 2016-03-23 |
US9480671B2 (en) | 2016-11-01 |
ES2570774T3 (es) | 2016-05-20 |
MX2011010229A (es) | 2011-10-11 |
US20120029080A1 (en) | 2012-02-02 |
US20130296428A1 (en) | 2013-11-07 |
AU2010230362B2 (en) | 2015-01-15 |
RU2559646C2 (ru) | 2015-08-10 |
MY161505A (en) | 2017-04-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL2413718T3 (pl) | Zastosowanie kwasu arachidonowego do zmniejszenia ryzyka insulinooporności w późniejszym życiu | |
GB2470483B (en) | Improvements in the management of medical tubing | |
IL209451A (en) | Catheter with coil electrode | |
GB2494493B (en) | Patient interface and aspects thereof | |
GB2506304B (en) | Patient interface and aspects thereof | |
HUE037149T2 (hu) | Katéter testreszabható csatlakozóval | |
EP2414535A4 (en) | BIOMARKERS RELATED TO INSULIN RESISTANCE AND METHODS OF USE | |
IL208291A0 (en) | Assemblies for use with an endoscope | |
HK1171361A1 (zh) | 帶有制動器的輪椅 | |
ZA201204048B (en) | Clinical syringe | |
EP2499034A4 (en) | WHEELCHAIR | |
EP2504469A4 (en) | ELECTROLYTE SOLUTION AND METHODS OF ELECTROPOLISHING | |
EP2505117A4 (en) | MEDICAL DEVICE WITH MULTIPLE CURVES | |
IL200080A0 (en) | Singular wheelchair | |
EP2478927A4 (en) | CATHETER | |
HK1171650A1 (en) | Electrode catheter | |
HK1169993A1 (en) | Hsl inhibitors useful in the treatment of diabetes hsl | |
EP2390375A4 (en) | ALLOY FOR MEDICAL USE AND MEDICAL DEVICE | |
IL215265A0 (en) | Syringe for single use | |
EP2453742A4 (en) | IBUPROFEN TREATMENT INTRAVENOUSLY | |
EP2455090A4 (en) | MEANS TO INHIBIT THE INCREASE OF THE POSTPRANDIAL BLOOD INSULIN MIRROR | |
GB0908425D0 (en) | Medical use | |
GB0921060D0 (en) | Catheter | |
HK1174815A1 (en) | Electrode catheter | |
HU0900178D0 (en) | Stronger paper-pallet with use of simple geometrical structure |